UCLA-industry partnership to develop, commercialize new nano...(es reducing drug toxicity dramatically a...),Health

The concept is a simple one that is open to infinite variation, and significant applications of the new technology are anticipated in other major commercial areas, including scents and cosmetics, food products, environmental remediation, construction materials, and defense.

The California NanoSystems Institute fosters interdisciplinary collaborations in nanoscience and nanotechnology research and facilitates partnerships with private industry, fueling economic development and ensuring the social well-being of California, the United States and the world.

"This collaboration underscores many key objectives of the CNSI," said Leonard H. Rome, CNSI interim director and senior associate dean of research at the David Geffen School of Medicine at UCLA. "The faculty members involved in the Nano Machine Center at CNSI are developing exciting technologies which have the potential to generate major advances in healthcare and medical treatment."

"We are looking forward to launching this collaboration and working in a seamless fashion with UCLA and the world-class scientific team at the CNSI to develop and commercialize nanotechnology," said Joseph A. Boystak, chairman and co-chief executive officer of NanoPacific Holdings. "We intend to prioritize and aggressively pursue multiple applications in the medical, consumer, environmental and industrial sectors, and in doing so, we envision spawning a series of companies and partnerships with important commercial partners to accelerate the roll-out of this technology."

"I am delighted to be part of the team that provides a bridge from the cutting-edge research being done at the CNSI to industry," said Michael B. Flesch, vice chairman and co-CEO of NanoPacific. "This step is a profound one for NanoPacific Holdings a
'/>"/>